PMID- 31049416
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220408
IS  - 2398-3795 (Electronic)
IS  - 2398-3795 (Linking)
VI  - 3
IP  - 1
DP  - 2019 Apr
TI  - Exploring the relationship between coronary heart disease and type 2 diabetes: a 
      cross-sectional study of secondary prevention among diabetes patients.
PG  - bjgpopen18X101636
LID - 10.3399/bjgpopen18X101636 [doi]
LID - bjgpopen18X101636
AB  - BACKGROUND: Coronary heart disease (CHD) and stroke are the major causes of death 
      among people with diabetes. AIM: To describe the prevalence and onset of CHD and 
      stroke among patients with type 2 diabetes mellitus (T2DM) in primary care in 
      Norway, and explore the quality of secondary prevention. DESIGN & SETTING: A 
      cross-sectional study of data was undertaken from electronic medical records 
      (EMRs) of 10 255 patients with T2DM in general practice. The study took place in 
      five counties of Norway (Oslo, Akershus, Rogaland, Hordaland, and Nordland). 
      Quality of care was assessed based on national guideline recommendations. METHOD: 
      Summary statistics with adjustments and binary logistic regression models were 
      used. RESULTS: In total, 2260 patients (22.1%) had CHD and 759 (7.4%) had stroke. 
      South Asians had significantly more CHD than ethnic Norwegians (29.5%, 95% 
      confidence interval [CI] = 26.1 to 33.0 versus 21.5%, CI = 20.6 to 22.3) and 
      other ethnic groups, and experienced onset of CHD or stroke at a mean of 7 years 
      before Norwegians. In 47.9% of the patients, CHD was diagnosed before T2DM. 
      Treatment target for low-density lipoprotein (LDL) cholesterol was reached for 
      30.0% and for systolic blood pressure (SBP) for 65.1% of the patients with CHD. 
      Further, 20.9% of patients with CHD were present smokers, and only 5.0% of 
      patients reached all four treatment targets (no smoking, HbA1c </=7.0%, SBP <135 
      mmHg, LDL-cholesterol <1.8 mmol/l). CONCLUSION: The diagnosis of CHD preceded the 
      diagnosis of T2DM in half of the patients. The prevalence of CHD was highest and 
      onset earlier among ethnic South Asians. More intensive treatment of lipids, 
      blood pressure, and smoking are needed in patients with T2DM and CHD.
FAU - Gjelsvik, Bjorn
AU  - Gjelsvik B
AD  - Assistant Professor, Department of General Practice, General Practice Research 
      Unit (AFE), Institute of Health and Society, University of Oslo, Oslo, Norway.
FAU - Tran, Anh Thi
AU  - Tran AT
AD  - Researcher, Department of General Practice, General Practice Research Unit (AFE), 
      Institute of Health and Society, University of Oslo, Oslo, Norway.
FAU - Berg, Tore J
AU  - Berg TJ
AD  - Assistant Professor, Institute of Clinical Medicine, Faculty of Medicine, 
      University of Oslo, Oslo, Norway.
AD  - Senior Consultant, Department of Endocrinology, Morbid Obesity and Preventive 
      Medicine, Oslo University Hospital, Oslo, Norway.
FAU - Bakke, Asne
AU  - Bakke A
AD  - Senior Consultant, Department of Medicine, Stavanger University Hospital, 
      Stavanger, Norway.
AD  - PhD Fellow, Department of Global Public Health and Primary Care, University of 
      Bergen, Bergen, Norway.
FAU - Mdala, Ibrahimu
AU  - Mdala I
AD  - Statistician, Department of General Practice, General Practice Research Unit 
      (AFE), Institute of Health and Society, University of Oslo, Oslo, Norway.
FAU - Nokleby, Kjersti
AU  - Nokleby K
AD  - PhD Fellow, Department of General Practice, General Practice Research Unit (AFE), 
      Institute of Health and Society, University of Oslo, Oslo, Norway.
FAU - Cooper, John G
AU  - Cooper JG
AD  - Researcher, Norwegian Quality Improvement of Laboratory Examinations, 
      Haraldsplass Deaconess Hospital, Bergen, Norway.
AD  - Senior Consultant, Department of Medicine, Stavanger University Hospital, 
      Stavanger, Norway.
FAU - Claudi, Tor
AU  - Claudi T
AD  - Senior Consultant, Department of Medicine, Nordland Hospital, Bodo, Norway.
FAU - Lovaas, Karianne Fjeld
AU  - Lovaas KF
AD  - Section Head, Norwegian Quality Improvement of Laboratory Examinations, 
      Haraldsplass Deaconess Hospital, Bergen, Norway.
FAU - Thue, Geir
AU  - Thue G
AD  - Professor, Department of Global Public Health and Primary Care, University of 
      Bergen, Bergen, Norway.
AD  - Professor, Norwegian Quality Improvement of Laboratory Examinations, Haraldsplass 
      Deaconess Hospital, Bergen, Norway.
FAU - Sandberg, Sverre
AU  - Sandberg S
AD  - Professor, Laboratory of Clinical Biochemistry, Haukeland University Hospital, 
      Bergen, Norway.
AD  - Professor, Department of Global Public Health and Primary Care, University of 
      Bergen, Bergen, Norway.
AD  - Director, Norwegian Quality Improvement of Laboratory Examinations, Haraldsplass 
      Deaconess Hospital, Bergen, Norway.
FAU - Jenum, Anne K
AU  - Jenum AK
AD  - Professor, Department of General Practice, General Practice Research Unit (AFE), 
      Institute of Health and Society, University of Oslo, Oslo, Norway.
LA  - eng
PT  - Journal Article
DEP - 20190320
PL  - England
TA  - BJGP Open
JT  - BJGP open
JID - 101713531
PMC - PMC6480851
OTO - NOTNLM
OT  - coronary heart disease
OT  - general practice
OT  - primary care
OT  - secondary prevention
OT  - stroke
OT  - type 2 diabetes
COIS- The authors declare that no competing interests exist.
EDAT- 2019/05/03 06:00
MHDA- 2019/05/03 06:01
PMCR- 2019/03/20
CRDT- 2019/05/04 06:00
PHST- 2018/12/05 00:00 [received]
PHST- 2018/12/17 00:00 [accepted]
PHST- 2019/05/04 06:00 [entrez]
PHST- 2019/05/03 06:00 [pubmed]
PHST- 2019/05/03 06:01 [medline]
PHST- 2019/03/20 00:00 [pmc-release]
AID - 01636 [pii]
AID - 10.3399/bjgpopen18X101636 [doi]
PST - epublish
SO  - BJGP Open. 2019 Mar 20;3(1):bjgpopen18X101636. doi: 10.3399/bjgpopen18X101636. 
      eCollection 2019 Apr.